KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Cash & Equivalents (2016 - 2025)

Maxlinear (MXL) has disclosed Cash & Equivalents for 16 consecutive years, with $72.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 7158.82% to $72.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $72.8 million, a 7158.82% increase, with the full-year FY2025 number at $72.8 million, up 7158.82% from a year prior.
  • Cash & Equivalents was $72.8 million for Q4 2025 at Maxlinear, up from $1.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $187.3 million in Q4 2023 to a low of $105000.0 in Q4 2021.
  • A 5-year average of $73.9 million and a median of $36.9 million in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 18972.1% in 2023, then crashed 99.46% in 2024.
  • Maxlinear's Cash & Equivalents stood at $105000.0 in 2021, then soared by 835.24% to $982000.0 in 2022, then skyrocketed by 18972.1% to $187.3 million in 2023, then plummeted by 99.46% to $1.0 million in 2024, then soared by 7158.82% to $72.8 million in 2025.
  • Per Business Quant, the three most recent readings for MXL's Cash & Equivalents are $72.8 million (Q4 2025), $1.0 million (Q4 2024), and $187.3 million (Q4 2023).